XML 72 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Shareholders' Equity (Tables)
12 Months Ended
Oct. 31, 2012
Equity [Abstract]  
Schedule Of Stock Option Activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended

 

 

October 31, 2012

 

October 31, 2011

 

 

 

 

Weighted

 

 

 

Weighted

 

 

 

 

Average

 

 

 

Average

 

 

 

 

Exercise

 

 

 

Exercise

 

 

Shares

 

Price

 

Shares

 

Price

Outstanding at beginning of year

 

346,572 

 

$

6.31 

 

600,573 

 

$

6.12 

Exercised

 

(27,500)

 

 

3.52 

 

(49,500)

 

 

2.76 

Expired or cancelled

 

(33,000)

 

 

6.41 

 

(204,501)

 

 

6.61 

Outstanding at end of period

 

286,072 

 

$

6.57 

 

346,572 

 

$

6.31 

 

Schedule Of Stock Options Outstanding

 

 

 

 

 

 

 

 

 

 

Exercise Prices

 

Number Outstanding and Subject to Exercise

 

Weighted Average Remaining Contractual Life

$2.00

 

1,150 

 

0.93 

2.53

 

4,000 

 

0.83 

5.08

 

48,000 

 

1.48 

5.16

 

35,584 

 

2.80 

5.66

 

10,000 

 

2.55 

6.23

 

24,500 

 

1.54 

6.60

 

36,697 

 

1.71 

7.79

 

41,500 

 

0.93 

7.86

 

84,641 

 

1.83 

Total

 

286,072 

 

1.73 

 

Schedule Of Restricted Stock Activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended

 

 

October 31, 2012

 

October 31, 2011

 

 

 

 

Weighted

 

 

 

Weighted

 

 

 

 

Average

 

 

 

Average

 

 

 

 

Grant Date

 

 

 

Grant Date

 

 

Shares

 

Fair Value

 

Shares

 

Fair Value

Unvested at beginning of year

 

126,852 

 

$

4.12 

 

101,327 

 

$

3.11 

Granted

 

69,114 

 

 

5.51 

 

148,545 

 

 

4.51 

Vested

 

(78,229)

 

 

3.98 

 

(52,465)

 

 

3.70 

Forfeited

 

(16,666)

 

 

3.85 

 

(70,555)

 

 

3.79 

Unvested at end of year

 

101,071 

 

$

5.23 

 

126,852 

 

$

4.12 

 

Schedule Of Pre-Tax Stock-Based Compensation Expense Recognized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

 

2012

 

2011

Cost of revenues

 

$

16 

 

$

Selling and marketing

 

 

43 

 

 

102 

General and administrative

 

 

322 

 

 

205 

Research and development

 

 

30 

 

 

33 

Stock-based compensation expense

 

$

411 

 

$

346